Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

EHC vs ACHC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ACHC Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 3–7 Matrix Metrics)

ACHC Overall Winner 6-Pillar Tally: EHC 3 – 3 ACHC Matrix Metrics: EHC 7 – 3 ACHC

As of Nov 20, 2026, Acadia Healthcare Company, Inc. (ACHC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 3–7 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Options & Positioning, R&D & Supply-Chain Moat). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas ACHC carries 33.1/100 (SELL) at $34.60 (17.0x Forward P/E, 9.8% operating margin).

  • Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. ACHC 33.1/100 SELL), ACHC captures the overall institutional head-to-head verdict (3–7 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (9.8% vs. 18.4% operating margin) and revenue trajectory (+5.1% vs. +8.9% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EHC vs ACHC
EHC NYSE
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
TTM Revenue $6.34B
Forward P/E 19.4x
Beta / 30D Vol -0.10β · 40% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.8 · SMA20: $135.78 · SMA50: $128.15
ACHC NASDAQ Head-to-Head Winner
Acadia Healthcare Company, Inc.
Services-Specialty Outpatient Facilities, Nec
$34.60
+0.38% 1D
Market Cap $3.2B
TTM Revenue $3.41B
Forward P/E 17.0x
Beta / 30D Vol 0.68β · 61% Vol
Unified Composite Score
33.1 / 100 SELL
Tech 15.0 Fund 36.0 Flow 59.0 Mom 36.4
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.1% over 20 days), RSI 52
RSI-14: 51.8 · SMA20: $34.42 · SMA50: $31.28

6-Pillar Scorecard Institutional Category Breakdown (EHC 3 – 3 ACHC)

Columns: Metric · EHC · ACHC
1. Valuation Multiples ACHC
Forward P/E 19.4x 17.0x
Trailing P/E 21.2x 16.9x
PEG Ratio 0.41x 1.37x
EV / Revenue 2.5x 1.6x
2. Growth & Scale EHC
Revenue Growth (YoY) +8.9% +5.1%
Earnings Growth (YoY) +21.6% -5.1%
TTM Revenue (USD) $6.34B $3.41B
Market Cap $13.0B $3.2B
3. Profitability & Quality EHC
Gross Margin 44.1% 41.0%
Operating Margin 18.4% 9.8%
Net Profit Margin 10.2% -33.1%
Return on Equity (ROE) 25.1% -40.5%
4. Balance Sheet & Cash Flow EHC
Cash Generation (TTM) $457M -$24M
Cash Flow Margin 7.2% -0.7%
Net Cash / Leverage $2.73B Net Debt (1.05x D/E) $2.34B Net Debt (1.24x D/E)
Dividend Yield 0.58% None (0.00%)
5. Options & Positioning ACHC
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 27.0% (8th %ile) 49.8% (31st %ile)
Put/Call OI Skew 0.25x (Call-Skewed) 0.39x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat ACHC
OpEx & R&D Intensity 25.7% of Rev ($1.63B) 31.2% of Rev ($1.06B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EHC (7) vs ACHC (3)
Institutional Metric EHC ACHC Criterion Row Edge
Market Capitalization
Scale
$13.0B $3.2B Larger Scale EHC
Trailing P/E Ratio
Valuation
21.2x 16.9x Lower Multiple ACHC
Forward P/E Ratio
Valuation
19.4x 17.0x Lower Multiple ACHC
Revenue Growth (YoY)
Growth
+8.9% +5.1% Higher Growth EHC
Operating Margin (TTM)
Profitability
18.4% 9.8% Higher Margin EHC
Net Profit Margin
Profitability
10.2% -33.1% Higher Margin EHC
Return on Equity (ROE)
Capital Efficiency
25.1% -40.5% Higher ROE EHC
52-Week Range Position
Momentum
80% ($93–$144) 82% ($11–$40) Stronger Trend ACHC
Beta / 30D Volatility
Risk Regime
-0.10β · 40% Vol 0.68β · 61% Vol Lower Realized Risk EHC
Unified Institutional Score
Composite Signal
52.0 / 100 (HOLD) 33.1 / 100 (SELL) Higher Composite EHC
Trailing 12M Revenue (USD)
Operating Scale
$6.34B $3.41B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.1% 41.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.41x PEG · 2.5x EV/Rev 1.37x PEG · 1.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$457M ($2.73B Net Debt (1.05x D/E)) -$24M ($2.34B Net Debt (1.24x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ACHC +2.47 pp
EHC: +6.06% · ACHC: +8.53%
3M Horizon ACHC +9.94 pp
EHC: +10.53% · ACHC: +20.47%
6M Horizon ACHC +21.94 pp
EHC: +27.33% · ACHC: +49.27%
1Y Horizon ACHC +121.86 pp
EHC: +19.42% · ACHC: +141.28%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period EHC Revenue ACHC Revenue EHC Op. Margin ACHC Op. Margin Margin Leader
FY2018 $4.28B $1.90B 13.0% 31.2% ACHC
FY2019 $4.61B $2.01B 13.3% 29.2% ACHC
FY2020 $3.57B $2.09B 15.8% -32.2% EHC
FY2021 $4.01B $2.31B 13.9% 8.2% EHC
FY2022 $4.35B $2.61B 12.4% 10.5% EHC
FY2023 $4.80B $2.93B 7.3% -0.7% EHC
FY2024 $5.37B $3.15B 8.5% 8.1% EHC
FY2025 $5.94B $3.31B 9.5% -33.3% EHC

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EHC CONSOLIDATION
73d in phase · OBV DISTRIBUTION
Current IV 27.0%
IV Percentile 8th %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACHC CONSOLIDATION
87d in phase · OBV NEUTRAL
Current IV 49.8%
IV Percentile 31st %ile
Put/Call OI Skew 0.39x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact ACHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $38.10 · IV 47.7%

ACHC Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($3,810)

Compare $3,810 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 47.7% ATM IV.

PUT-WALL MONTHLY INCOME Liq C

Jan 15 '27 $35 / $30 Bull Put Spread

Sell 1x $35P · Buy 1x $30P · 59d

Net Entry $112 Credit
Max Credit / Yield +$112 (+28.9% RoM)
Max Risk / Buffer -11.1% Cushion ($388 Mgn)
5d Edge & Liquidity 71% PoP · Liq C
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq C

Dec 18 $40 / $35 Bear Put Spread

Buy 1x $40P · Sell 1x $35P · 31d

Net Entry $220 Debit
T+5d @ -5% Drop +$73 (+33%)
Max Risk / Buffer $220 Capped
5d Edge & Liquidity 0.9x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EHC Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($1.63B)
90D Engineering Disclosures 0 Published
ACHC Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $3.2B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment 31.2% of Rev ($1.06B)
90D Engineering Disclosures 0 Published

Investor FAQ EHC vs ACHC Key Questions & Quantitative Answers

As of Nov 20, 2026, Acadia Healthcare Company, Inc. (ACHC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 3–7 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Options & Positioning, R&D & Supply-Chain Moat). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas ACHC carries 33.1/100 (SELL) at $34.60 (17.0x Forward P/E, 9.8% operating margin). Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. ACHC 33.1/100 SELL), ACHC captures the overall institutional head-to-head verdict (3–7 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (9.8% vs. 18.4% operating margin) and revenue trajectory (+5.1% vs. +8.9% YoY).

EHC leads the Growth & Scale pillar: EHC posts +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin), compared with ACHC at +5.1% YoY revenue growth and -5.1% YoY earnings growth on $3.41B TTM revenue (41.0% gross margin, 9.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), EHC cumulative revenue shifted +38.8% while ACHC shifted +74.2%. In operating R&D and SG&A reinvestment, EHC deploys 25.7% of Rev ($1.63B) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($1.06B) (0 disclosures) for ACHC.

ACHC screens cheaper on headline valuation multiples. EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin), whereas ACHC trades at 17.0x Forward P/E, 16.9x Trailing P/E, 1.37x PEG, and 1.6x EV/Revenue (-0.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHC (25.1% ROE) versus ACHC (-40.5% ROE) capital efficiency.

In options market volatility and institutional positioning, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk). By comparison, ACHC carries 49.8% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 0.39x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.68β · 61% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.